Bumper Offer - Urjas oil Just @ Rs. 1
Prolomet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of High BP. Other than this, Prolomet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Prolomet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The most common side effects of Prolomet are Slow heart rate (pulse). Besides the aforementioned side effects, there are other adverse effects of Prolomet as well, which are listed below. Usually, these side effects of Prolomet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Prolomet has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, Prolomet's effects on the liver, heart and kidney are discussed below in the Prolomet related warnings section.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate) must refrain from the use of Prolomet since this can cause severe adverse effects. Other conditions have been mentioned below in the Prolomet contraindications section.
Drug reaction of Prolomet with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Prolomet is not safe while driving, and is is not addictive in nature.
Prolomet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Prolomet is used -
Moderate
Mild
Common
Is the use of Prolomet safe for pregnant women?
Prolomet should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Prolomet safe during breastfeeding?
Prolomet may have very limited harmful effects for breastfeeding women.
What is the effect of Prolomet on the Kidneys?
Using Prolomet does not have any harmful effects on kidneys.
What is the effect of Prolomet on the Liver?
Prolomet may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Prolomet on the Heart?
Prolomet is rarely harmful for the heart.
Prolomet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Prolomet unless your doctor advises you to do so -
Is this Prolomet habit forming or addictive?
Forming a habit of Prolomet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Prolomet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Prolomet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Prolomet cannot treat any kind of mental disorder.
Interaction between Food and Prolomet
Eating certain foods may increase the time it takes Prolomet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Prolomet
Taking Prolomet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
